At Cambridge Therapeutics, based in Teaneck, New Jersey, chairman John Klein directs the work of teams dedicated to innovation in medical products and pharmaceutical packaging. In keeping with his professional focus on helping to deliver high-quality medical care, Cambridge Therapeutics founder John Klein additionally serves on the board of trustees of Hackensack Meridian Health Hospitals.
Affiliated with Hackensack University Medical Center, HMH has developed the Center for Discovery and Innovation, which works to take pioneering techniques in biomedicine and harness them as a means of improving outcomes for patients with debilitating or life-threatening diseases, and as a way to prevent major diseases entirely. The center’s founders believed that the technological innovations of the 21st century can and should inform medical treatment more thoroughly for the benefit of patients and communities.
The center makes use of advances in the fields of genetics and genomics, bioengineering, immunology, and cellular and stem-cell biology, particularly in the treatment of cancer. The regenerative medical programs at the center also aim to discover the best ways of restoring tissues or entire organs damaged through injury or disease.
Among the individual units of the center are the Institute for Cancer and Infectious Diseases, and another institute dedicated to exploring best treatments for multiple myeloma.